What Is GILD Fair Value?
Gilead Sciences Inc. (GILD) fair value estimate using multiple valuation models, updated daily.
As of September 16, 2026, Gilead Sciences Inc. (GILD) has a composite fair value estimate of $206.41 based on four valuation models: DCF (70% weight), Graham Number (0% weight), PEG (0% weight), and DDM (30% weight). The current market price is $147.68, suggesting the stock is undervalued by 39.8%.
Data as of September 16, 2026 (today)
Composite Fair Value
Undervalued2 of 4 models$206.41
vs. current price of $147.68(+39.8%)
How Is GILD Fair Value Calculated?
Four independent models estimate what GILD is worth. Each uses different inputs and assumptions. The composite blends them by weight.
GILD Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
70% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$219.43
+48.6%Undervalued
Inputs used
DDM (Dividend Discount Model)
30% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$85.66
-42.0%Overvalued
Inputs used
GILD Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
0% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
N/A
Requires positive EPS and book value. Gilead Sciences Inc. currently has negative earnings, so the Graham formula cannot be applied.
Inputs used
PEG (Price/Earnings to Growth)
0% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
N/A
Requires positive earnings per share. Gilead Sciences Inc. is not yet profitable, so the PEG model cannot calculate a fair price.
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $147.68 is 48.6% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $10.26B | $9.67B |
| Year 2 | $10.77B | $9.56B |
| Year 3 | $11.31B | $9.46B |
| Year 4 | $11.87B | $9.36B |
| Year 5 | $12.47B | $9.27B |
| Year 6 | $13.09B | $9.17B |
| Year 7 | $13.75B | $9.07B |
| Year 8 | $14.43B | $8.98B |
| Year 9 | $15.15B | $8.88B |
| Year 10 | $15.91B | $8.79B |
| Terminal Value | $451.22B | $249.25B |
What Are GILD's Key Financial Metrics?
Earnings & Growth
Current Price
$147.68
EPS (TTM)
-$2.65
Forward P/E
14.9
Profit Margin
-10.6%
Cash & Balance Sheet
Free Cash Flow
9.8B
EBITDA
14.6B
Book Value
$9.53
Total Debt
26.2B
What Do Analysts Say About GILD?
Low
$123.00
Average
$158.15
High
$180.00
Upside
+7.1%
GILD Fair Value FAQ
What is the fair value of GILD?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), GILD's estimated fair value is $206.41. The stock is currently trading at $147.68, which makes it undervalued by our analysis.
How is GILD's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is GILD overvalued or undervalued?
Based on our analysis, GILD is undervalued. The current price of $147.68 is 39.8% below our estimated fair value of $206.41.
What do Wall Street analysts say about GILD?
27 analysts cover Gilead Sciences Inc. with a consensus rating of "Buy." The average price target is $158.15, ranging from $123.00 to $180.00. This implies 7.1% upside from the current price.